2026-09-06 · 2026-09 / week-1
KFY's cash cushion is real, but the September 9 guide still cannot clear the 10/5 hurdle
KFY's cash cushion is real, but the September 9 guide still cannot clear the 10/5 hurdle
Run timestamp: 2026-09-06 07:32 SGT Scope: U.S. market, long only Classification: No-trade screen, Reject for current execution Primary instrument: KFY common stock, NYSE, unlevered only if every execution gate later passes
Summary: Korn Ferry enters its September 9 fiscal Q1 2027 release with a useful disagreement. The company finished FY26 with fee revenue up 7%, adjusted EBITDA of $497.8 million, and a balance sheet that contained more cash than debt. The stock closed at $85.35, near its recent range, while the provider reports a $3.80 billion enterprise value and 9.22x trailing EV to EBITDA. A modest operating beat and a return toward an 8.5x adjusted EBITDA multiple can produce a reference-only base target of $99.70, or +16.81%.
The downside is not bounded at 5%. A staffing and consulting slowdown, margin compression, geopolitical shock, or a reset of the multiple can produce a $74.63 bottom case, or -12.56%. The probability-weighted reference target is $95.49, or +11.88% before costs, but gross reward to adverse risk is only 1.34:1. KFY is the best long research candidate in this screen, not a trade-qualified signal.
Opportunity Ranking
The search used mechanism-specific combinations rather than a generic earnings query:
professional services fee revenue cash net debt buyback labor market guide reset September 9 2026
hospital ambulatory EBITDA repurchase payer mix debt conference September 9 2026
newly public franchise royalty same-store sales debt denominator Q2 results September 9 2026
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | KFY | Long | Cash and durable fee growth can support a rerating, but the market is already near the provider's adjusted fair value | Sep. 2 earnings notice, June 23 FY26 result, June 26 10-K | Sep. 9 FY27 Q1 release and call | 2.22M shares short, 4.36% of shares, 5.92 DTC in current provider data | Base +16.81%, adverse -12.56%, ratio 1.34:1, Reject | NYSE and observable volume; current spread, depth, venue, and exit audit missing | Hiring-cycle slowdown and guide compression |
| 2 | THC | Long | Q2 operating strength and buybacks support value, but the stock already repriced sharply after the print | July 23 Q2 release and July 29 10-Q | Sep. 9 healthcare conference | 2.52M shares short, 3.16% of public float, 3.1 DTC at Aug. 14 | No clean adverse bound below 5%; Reject | Liquid NYSE name; leverage and payer concentration remain | Debt, reimbursement, payer mix, and post-rally profit taking |
| 3 | JMKE | Long | Asset-light franchise growth is attractive, but the post-IPO denominator and debt claims are not yet clean | July 29 prospectus and Sep. 2 results notice | Sep. 9 first public Q2 result | Positioning and current economic denominator incomplete | Insufficient clean EV and downside evidence; Watchlist | NYSE volume is visible, but first-report price acceptance is untested | Franchise demand, leverage, earnout, and Class A or HoldCo claims |
The selected opportunity is KFY. It has the strongest combination of a dated information event, a reconciled operating history, and a cash bridge among the candidates. THC has the strongest reported operating numbers, but its price has risen from $199.02 on July 23 to $265.05 on September 4. JMKE has genuine franchise economics, but its recently listed equity claims and HoldCo units require a denominator reconstruction before a responsible per-share value.
Selected opportunity: KFY, long research only. Why this one now: The next primary observation arrives before the market has another quarter to absorb the labor-cycle evidence. KFY's FY26 fee revenue, adjusted EBITDA, cash, debt, and Q1 guide are auditable, while the reference price still allows a direct multiple and cash-conversion test. What should surprise the reader: Net cash is supportive, but it is not a floor. The stock can be cheap on normalized EBITDA and still fail the 10/5 hurdle when the earnings event can reset fee revenue and the valuation multiple together.
Why This Is the Best Opportunity Right Now
The June 23 FY26 release reported Q4 fee revenue of $759.8 million, up 7% year over year, and Q4 adjusted EBITDA of $129.5 million. Full-year fee revenue was $2.9075 billion, up 7%, and adjusted EBITDA was $497.8 million, up from $463.9 million. Management guided Q1 FY27 fee revenue to $725 million to $745 million and diluted EPS to $1.32 to $1.38. FY26 results and outlook
The June 26 10-K reported $1.095 billion of cash, $38.9 million of current marketable securities, and $398.6 million of long-term debt at April 30. It also reported 50.225 million shares outstanding and $116.1 million of FY26 repurchases. The filed balance sheet implies approximately $735.8 million of cash and current securities less long-term debt before considering restricted or deferred-compensation assets. FY26 Form 10-K
This is a better evidence chain than a narrative turnaround. It is still not a free option. KFY's own outlook assumes no material negative impact from the Middle East conflict and stable geopolitical, economic, financial-market, and foreign-exchange conditions. A disappointing guide can overwhelm the cash bridge.
Why This Can Move More Than 5% Soon
The company will release Q1 FY27 results before the market opens on Wednesday, September 9, followed by a noon Eastern conference call. Earnings announcement
At $85.35, a return to the base case requires two linked outcomes: fee revenue at or above the guide, and a market multiple that recognizes the cash and steady adjusted EBITDA rather than treating the business as a late-cycle staffing agency. The top case requires a beat, stable margins, and a multiple closer to 9.0x adjusted EBITDA. The bottom case requires only a weaker guide or a lower multiple, not a balance-sheet failure.
10/5 Asymmetry Gate
The holding window is the September 9 release through October 30, 2026, or the first earlier filing that materially reconciles the quarter. The target map is an indicative EV to adjusted EBITDA bridge. The quote, provider market capitalization, filed balance sheet, and provider share count do not share one audit timestamp, so the entire calculation is reference-only.
| Measure | Reference-only result | Interpretation |
|---|---|---|
| Reference price | $85.35 | Regular-session close at 2026-09-04 20:00:00Z |
| Base target | $99.70 | +16.81% from reference |
| Bottom target | $74.63 | -12.56% from reference |
| Gross reward to adverse risk | 1.34:1 | Fails the 2:1 requirement |
| Probability-weighted target | $95.49 | +11.88% price-only expected move before costs |
| Measurement basis | Reference-only | entry.price is null |
| Status | Reject for current execution | No trade |
The favorable base move clears +10%, but the adverse path is wider than 5% and the ratio is below 2:1. The failure is economic before spread, slippage, gap, carrying cost, or exit uncertainty.
What Should Surprise the Reader
- The cash bridge is meaningful but cannot protect a stock through an earnings reset. A cash balance does not guarantee distribution, and some securities support deferred-compensation obligations.
- A 7% fee-revenue increase is not the same as a durable labor-market recovery. Digital fee revenue was flat for FY26, while Professional Search and Interim grew 11%.
- The company can beat EPS and still lose value if the guide points to slower fee revenue, higher compensation, or lower conversion of cash into repurchases.
The Setup
Korn Ferry is a global consulting, executive-search, professional-search, interim, recruitment-process-outsourcing, and digital business. Its Q4 FY26 results showed growth across the larger operating lines, but the digital segment's FY26 fee revenue was flat. The key distinction is between current fee revenue and the multiple the market assigns to cyclical staffing and consulting cash flows.
The primary catalyst is not a new product launch. It is the first quarter of the new fiscal year. The September 9 release will show whether the Q1 guide was conservative, whether the 17.1% FY26 adjusted EBITDA margin holds, and whether cash and buyback capacity remain credible after the year-end balance sheet.
The Market Price
| Field | Observation | Timestamp or date | Source and limitation |
|---|---|---|---|
| KFY price | $85.35 | 2026-09-04 20:00:00Z | StockAnalysis history, regular-session close |
| Change | -$0.24, -0.28% | Same session | Same source |
| Open / high / low | $84.09 / $85.68 / $83.17 | Same session | Same source |
| Volume | 621,629 shares | Same session | Same source; current depth and exit quality unverified |
| Provider market cap | $4.34B | Sep. 4, 2026 | StockAnalysis market cap, provider field |
| Provider enterprise value | $3.80B | Sep. 4, 2026 | Same provider; not aligned with the April 30 filing |
| Provider share count | 50.86M | Sep. 5, 2026 | StockAnalysis statistics; April 30 filing reports 50.225M |
| After-hours | $84.15 | Sep. 4, 2026 23:43:00Z context | StockAnalysis history; not an entry audit |
The stock has risen 15.98% over the provider's 52-week window and trades above its 50-day average. The market is not ignoring KFY. It is waiting for the next fee-revenue and margin observation.
The Mispricing
Fact: FY26 fee revenue increased 7% and adjusted EBITDA increased to $497.8 million. KFY FY26 release
Fact: Management guided Q1 FY27 fee revenue to $725 million to $745 million and diluted EPS to $1.32 to $1.38. KFY FY26 release
Fact: The April 30 10-K reported $1.095 billion cash, $38.9 million current marketable securities, $398.6 million long-term debt, and 50.225 million shares outstanding. KFY Form 10-K
Inference: The reference price does not require a heroic operating recovery to support a higher equity value. A modest EBITDA improvement and an 8.5x multiple produce a double-digit price return in the illustrative bridge.
Unknown: The July 31 quarter's actual fee revenue, compensation ratio, cash flow, current debt, current securities, current denominator, and whether the FY26 buyback pace continued.
The mispricing is conditional: the market may be underpricing the durability of KFY's fee growth and balance-sheet flexibility, but the next report can disprove both within days.
The Positioning
StockAnalysis reports 2.22 million shares short, 4.36% of shares, and 5.92 days to cover. This is enough to create incremental demand after a clean beat, but it is not a crowded squeeze setup. The same provider reports a 50.39 million share float. KFY statistics
This is medium positioning tension, not a primary thesis. The data is provider-reported and settlement-dated. Live borrow, utilization, recall terms, options exposure, top of book, and depth are not verified. Positioning score: 3/5.
The Catalyst
| Step | State | Timing | Observable test | Failure mode |
|---|---|---|---|---|
| Q1 FY27 release | Scheduled | September 9, 2026 before market open | Read fee revenue, segment growth, compensation, adjusted EBITDA, EPS, operating cash, and current shares | Revenue or guide falls below the stated range |
| Management call | Scheduled | September 9, 2026 at 12:00 p.m. EDT | Test labor demand, client budgets, AI substitution, consultant utilization, and buyback priorities | Commentary weakens the guide or margin path |
| Cash and denominator bridge | Unobserved | Q1 filing or later | Reconcile cash, securities, debt, repurchases, restricted assets, and shares | Cash is less available or buyback capacity is lower than assumed |
| Price acceptance | Unobserved | First regular session after release | Verify close, volume, spread, depth, venue, and realistic exit liquidity | Initial gap fades or execution costs widen |
The cheapest falsification is the September 9 release itself. If fee revenue is below $725 million, diluted EPS is below $1.32, adjusted EBITDA margin falls, or management cuts the forward path, the reference-only thesis is rejected. If the report meets the guide but the market cannot hold the first regular-session move, the stock remains non-executable.
The Payoff
The scenarios use a transparent illustrative bridge. Inputs are in millions, except per-share values. The cash adjustment is $735.8 million, calculated from $1,095.445 million cash plus $38.914 million current marketable securities less $398.565 million long-term debt. The denominator is the provider's 50.86 million current shares, not the older 50.225 million filing figure.
Top: (9.0 x $530M + $735.8M) / 50.86M = $108.25
Base: (8.5 x $510M + $735.8M) / 50.86M = $99.70
Bottom: (6.8 x $450M + $735.8M) / 50.86M = $74.63
The top case assumes a clean Q1 beat, stable or improving margins, and a 9.0x multiple. The base assumes fee revenue near the guide, adjusted EBITDA of approximately $510 million on a forward basis, and an 8.5x multiple. The bottom assumes weaker labor demand, adjusted EBITDA nearer $450 million, and a 6.8x multiple. These are assumptions, not company guidance.
Net enterprise value cannot be computed responsibly from one aligned timestamp because the quote is September 4, the provider EV and denominator are current context, and the balance sheet is April 30. The bridge is price-only research, not a current liquidation value.
Price Target and Probability Map
| Scenario | Probability | Target / Level | Return / Payoff | Horizon | Conditions | Evidence Quality |
|---|---|---|---|---|---|---|
| Top Case | 24% | $108.25 | +26.84% | Sep. 9 through Oct. 30 | Beat, stable margin, buyback capacity, 9.0x multiple | Medium |
| Base Case | 51% | $99.70 | +16.81% | Sep. 9 through Oct. 30 | Guide holds, cash remains credible, 8.5x multiple | Medium |
| Bottom Case | 25% | $74.63 | -12.56% | Sep. 9 through Oct. 30 | Labor slowdown, guide cut, margin compression, or 6.8x multiple | Medium |
| Invalidation | n/a | Release or filing disproves fee-growth and cash-conversion path | Thesis broken, not a price stop | Any time in the window | Guide cut, material cash or denominator surprise, or failed operating bridge | High when filed |
Probability rationale: The 51% base reflects the existing guide, two consecutive quarters of fee growth, and FY26 cash and EBITDA evidence. The 24% top requires both an earnings beat and multiple expansion. The 25% bottom is higher than a routine downside weight because the company's own outlook is conditioned on macro stability and the stock's current price already discounts part of the recovery. These are analyst estimates, not observed frequencies.
Probability-weighted expected value: $95.49 price-only using the rounded scenario targets, or +11.88% against the $85.35 reference. This is not net expected value. Current market level and timestamp: $85.35 at 2026-09-04 20:00:00Z, regular-session close. Primary instrument: KFY common stock, NYSE, unlevered only after all gates pass. 10/5 favorable base move: +16.81% reference-only. 10/5 credible adverse move: -12.56% reference-only. Gross reward to adverse risk: 1.34:1 before costs. 10/5 measurement basis: Reference-only, not verified entry. 10/5 status: Reject for current execution. Confidence: Medium on reported FY26 facts and scheduled event; low to medium on the current balance-sheet bridge and target multiple.
The Kill Shot
The strongest counterparty argument is that KFY is already fairly valued. The provider reports a 9.22x trailing EV to EBITDA, a 14.75x forward PE, and an average analyst price target of $86. The stock is above its 50-day moving average and has risen 15.98% in the provider's 52-week view. A September 9 release that merely meets the guide may not produce the multiple expansion required by the base case.
The load-bearing assumption is not the existence of cash. It is the persistence of fee revenue and a 17% adjusted EBITDA margin while the labor market, client budgets, and geopolitical conditions remain uncertain. If that assumption fails, cash reduces but does not eliminate the downside.
What Could Go Wrong
- Fee revenue can fall below the $725 million to $745 million guide as clients delay hiring, consulting, or transformation work.
- Compensation and benefits can rise faster than fee revenue, compressing the 17.1% FY26 adjusted EBITDA margin.
- Digital fee revenue was flat for FY26, so the broader growth narrative may depend on cyclical search and consulting activity.
- Cash and securities can be less available than the simple bridge suggests because of deferred-compensation and other obligations.
- The provider denominator and April 30 filed denominator do not match, so the per-share bridge can be diluted or stale.
- The stock can gap after the release, and current spread, depth, venue quality, and exit liquidity are unverified.
- The company can continue repurchases without creating a near-term price catalyst, because authorization is not completed demand.
What Would Prove This Wrong
- Q1 FY27 fee revenue is at or above the guide, adjusted EBITDA margin holds, and management maintains or raises the forward path.
- The next filing reconciles current cash, securities, debt, repurchases, and shares without a material adverse surprise.
- The first regular-session close after the release holds the initial move with acceptable spread, depth, volume quality, and exit liquidity.
- Subsequent fee revenue remains positive across Professional Search, Executive Search, Consulting, and RPO without relying on a one-time benefit.
The thesis is invalidated by a guide cut, a material margin or cash-conversion break, a denominator surprise that removes the per-share benefit, or a failed price-acceptance audit. A missing gate blocks execution even if the operating facts improve.
Risk Audit
| Risk | Why it matters | Control before any expression |
|---|---|---|
| Earnings gap | The release is before the market open and can bypass a stop | Wait for the release and a regular-session close; no market order |
| Labor cycle | Search and consulting demand is tied to client hiring and budgets | Recheck fee revenue, segment growth, backlog-like contracted fees, and guide |
| Margin | Compensation can absorb fee growth | Require adjusted EBITDA and compensation evidence, not revenue alone |
| Cash and claims | Deferred compensation, securities, debt, and leases complicate net cash | Reconcile the next filing before using current cash as support |
| Positioning | Short interest can add demand but does not prove forced covering | Treat the provider data as dated context; do not underwrite a squeeze |
| Market structure | Top of book, spread, depth, venue, and exit liquidity are missing | Run a fresh regular-session execution audit |
Best Trade Strategy
Current expression: no trade. The correct research state is entry.price: null and execution.can_execute: false.
Reconsider unlevered KFY common stock only after the September 9 release, first regular-session price acceptance, current cash and denominator reconciliation, and a refreshed spread, depth, venue, volume, and exit audit. The trigger is evidence, not a price level. The current base case does not overcome the adverse bound and 2:1 ratio requirements.
Do not trade if the result, guide, current balance sheet, denominator, or market-structure evidence is missing. Do not use options, leverage, margin, market orders, or price-floor logic.
Sources
Selected thesis
- Korn Ferry FY26 results and Q1 FY27 outlook, June 23, 2026
- Korn Ferry Q1 FY27 earnings announcement, September 2, 2026
- Korn Ferry FY26 Form 10-K, filed June 26, 2026
- KFY regular-session price and volume history, September 4, 2026
- KFY market capitalization and enterprise value, September 4, 2026
- KFY statistics, share count, valuation, and short interest, last checked September 5, 2026
Candidate comparison
- Tenet Q2 2026 results and raised outlook, July 23, 2026
- Tenet Q2 2026 Form 10-Q, filed July 29, 2026
- Tenet September 9 healthcare conference notice, September 2, 2026
- THC regular-session price history, September 4, 2026
- Jersey Mike's September 9 Q2 results announcement, September 2, 2026
- Jersey Mike's IPO prospectus and capitalization, July 2026
- JMKE regular-session price history, September 4, 2026
Research Quality Scorecard
| Criterion | Score | Evidence |
|---|---|---|
| Market disagreement | 4/5 | Cash and fee growth support a rerating while the market prices a mature staffing multiple |
| Evidence base | 5/5 | Fresh event notice, official results, 10-K, current quote, and provider positioning data |
| Positioning and flows | 3/5 | Dated short-interest evidence; live borrow, options, and flow data missing |
| Catalyst path | 5/5 | A scheduled release, call, cash bridge, and price-acceptance test |
| Payoff architecture | 3/5 | Explicit upside bridge, but adverse risk and ratio fail the hurdle |
| Invalidation discipline | 4/5 | Guide, margin, cash, denominator, and execution invalidations are monitorable |
| Differentiated insight | 4/5 | Cash support is real but cannot cap the earnings-event drawdown |
| Client value | 5/5 | Gives a clear post-release checklist and refuses a weak setup |
| Total | 33/40 | Publishable no-trade research, Reject for current execution |
Score quality does not override the failed 10/5 economics.
Bottom Line
KFY is the best long candidate in this run because the September 9 event is close, the FY26 operating record is positive, and the cash bridge is more auditable than the alternatives. A clean beat can plausibly move the stock above $99.70 in the reference-only model.
The same model exposes why the Desk should not call it a trade. The adverse case is -12.56%, the gross ratio is 1.34:1, current execution data is missing, and the balance sheet and denominator are not aligned with the quote. Wait for the release and the filing bridge. The correct current decision is no trade.
AI Illustration Prompt
Create a restrained institutional research illustration for “The Mispricing Desk”: a dark consulting-firm valuation desk with a KFY ledger marked “$85.35” beside a calendar page stamped “September 9, FY27 Q1”; show three clean evidence cards labeled “$2.907B FY26 fee revenue,” “$497.8M adjusted EBITDA,” and “$735.8M cash less debt,” connected to a transparent valuation bridge with the levels “$108.25 / $99.70 / $74.63.” Place a subtle red gate labeled “10/5 fails at 1.34:1” between the desk and a trade ticket marked “NO TRADE.” Use charcoal, slate blue, muted copper, cream paper, realistic financial documents, no rockets, no generic candlesticks, no hype, no invented numbers, and a subtle readable “The Mispricing Desk” watermark.